Characterization of chronic myeloid leukemia stem cells

Though tyrosine kinase inhibitors have redefined the care of chronic myeloid leukemia (CML), these agents have not proved curative, likely due to resistance of the leukemia stem cells (LSC). While a number of potential therapeutic targets have emerged in CML, their expression in the LSC remains larg...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Gerber, Jonathan M., Qin, Lu, Kowalski, Jeanne, Smith, B. Douglas, Griffin, Constance A., Vala, Milada S., Collector, Michael I., Perkins, Brandy, Zahurak, Marianna, Matsui, William, Gocke, Christopher D., Sharkis, Saul J., Levitsky, Hyam I., Jones, Richard J.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3010878/
https://ncbi.nlm.nih.gov/pubmed/21132730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.21915
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items